Last reviewed · How we verify
NCT07203924
Prognostic Importance of Physical Activity in Geriatric Patients With Acute Coronary Syndrome
trial in Acute Coronary Syndromes in 207 participants. Completed in 11 September 2025.
1 September 2025
Quick facts
| Lead sponsor | Balikesir University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 207 |
| Start date | 4 December 2024 |
| Primary completion | 1 September 2025 |
| Estimated completion | 11 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Acute Coronary Syndromes — all drugs for Acute Coronary Syndromes →
- Geriatric Patients — all drugs for Geriatric Patients →
- Physical Activity Levels — all drugs for Physical Activity Levels →
Sponsor
Balikesir University
Who can join
65 and older, any sex, with Acute Coronary Syndromes or Geriatric Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study evaluated the relationship between physical activity level and prognosis in geriatric patients admitted to the emergency department with acute coronary syndrome (ACS). A total of 207 patients aged 65 years and older were included. Physical activity level was assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF) and compared with clinical outcomes and risk scores (TIMI, HEART, SVEAT). Results showed that patients with higher physical activity levels had lower rates of major adverse cardiac events (MACE) and mortality, as well as lower risk scores. The findings suggest that physical activity is an independent protective factor that improves prognosis in older patients with ACS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07203924
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Coronary Syndromes
Currently open trials in the same condition.
- NCT07123181 — Oregano and Basil Leaves and Coronary Artery Disease · NA · recruiting
- NCT06927739 — Focused Orticumab Research for Treating Inflammation in Coronary Arteries · Phase 2 · recruiting
- NCT06845826 — Point-of-Care Troponin Testing in the Emergency Department · NA · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
Other Balikesir University trials
Trials by the same sponsor.
- NCT07048093 — Development of Standard Guidelines for Relaxation Exercises in Patients With Chronic Neck Pain and Determination of Thei · NA · not yet recruiting
- NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
- NCT06856395 — Effect of Using Educational Robots During Vaccination on Fear and Pain in Children · NA · not yet recruiting
- NCT07103837 — Development, Validity, and Reliability of the Reactive Skill Test in Older Adults · NA · completed
- NCT07103824 — Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07203924 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Balikesir University
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07203924.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing